2017
DOI: 10.1016/j.gie.2017.07.028
|View full text |Cite
|
Sign up to set email alerts
|

Impact of mucosal inflammation on risk of colorectal neoplasia in patients with ulcerative colitis: a systematic review and meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
45
0
2

Year Published

2017
2017
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 72 publications
(47 citation statements)
references
References 114 publications
0
45
0
2
Order By: Relevance
“…Finally, in a recent meta-analysis of 1443 patients, the presence of endoscopic or histologic inflammation as well as histologic inflammation alone increased the risk of colorectal neoplasia (OR, 3.53; 95% CI, 2.59-4.80 and OR, 2.6; 95% CI, 1.49-4.46, respectively). 47…”
Section: Association Between Histologic Inflammation and The Developmmentioning
confidence: 99%
“…Finally, in a recent meta-analysis of 1443 patients, the presence of endoscopic or histologic inflammation as well as histologic inflammation alone increased the risk of colorectal neoplasia (OR, 3.53; 95% CI, 2.59-4.80 and OR, 2.6; 95% CI, 1.49-4.46, respectively). 47…”
Section: Association Between Histologic Inflammation and The Developmmentioning
confidence: 99%
“…Patients without signs of previous or ongoing inflammation have acquired less cumulative inflammatory damage over time. A decreased mutational burden translates into a decreased risk of developing aCRN 25. Moreover, endoscopically active disease, strictures and postinflammatory polyps all affect visibility during colonoscopy and thus the sensitivity of the colonoscopy itself for dysplasia and CRC detection.…”
Section: Discussionmentioning
confidence: 99%
“…Screening techniques included standard white-light colonoscopy (SD-WLE), high-definition white light colonoscopy (HD-WLE), dye chromoendoscopy (DCE), virtual chromoendoscopy (NBI, i-Scan, and FICE) and AFI. Patients presented with UC in the form of pancolitis or left colitis or DC with involvement of at least one-third or more of a segment of the colon, with a disease time of more than 8 years, or with primary sclerosing cholangitis, regardless of disease time [26][27][28]. There was no restriction of period, country or language of publication.…”
Section: Eligibility Criteriamentioning
confidence: 99%